Ralph Vogler

603 total citations
19 papers, 458 citations indexed

About

Ralph Vogler is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Ralph Vogler has authored 19 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 10 papers in Public Health, Environmental and Occupational Health and 7 papers in Genetics. Recurrent topics in Ralph Vogler's work include Acute Myeloid Leukemia Research (18 papers), Acute Lymphoblastic Leukemia research (10 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Ralph Vogler is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Acute Lymphoblastic Leukemia research (10 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Ralph Vogler collaborates with scholars based in United States, Canada and Belgium. Ralph Vogler's co-authors include Jack Goldberg, Hans Grünwald, George P. Browman, Azra Raza, Richard A. Larson, Harvey D. Preisler, John M. Bennett, Roger Day, A. Gottlieb and M M Gottesman and has published in prestigious journals such as Cancer, British Journal of Haematology and American Journal of Hematology.

In The Last Decade

Ralph Vogler

19 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralph Vogler United States	12	286	190	185	151	64	19	458
Makoto Yazaki Japan	13	269 0.9×	116 0.6×	106 0.6×	139 0.9×	36 0.6×	33	547
GP Bodey United States	8	350 1.2×	172 0.9×	223 1.2×	113 0.7×	59 0.9×	12	512
A. A. Bartolucci United States	6	283 1.0×	146 0.8×	137 0.7×	118 0.8×	50 0.8×	9	428
Muthalagu Ramanathan United States	11	243 0.8×	66 0.3×	103 0.6×	37 0.2×	41 0.6×	53	390
Motohiro Tsuzuki Japan	10	384 1.3×	343 1.8×	58 0.3×	108 0.7×	45 0.7×	27	518
Ellison Rr	4	228 0.8×	128 0.7×	104 0.6×	96 0.6×	49 0.8×	9	320
Bachar Samra United States	9	150 0.5×	97 0.5×	136 0.7×	113 0.7×	38 0.6×	18	364
P. Y. Leprise France	7	143 0.5×	172 0.9×	358 1.9×	173 1.1×	121 1.9×	8	575
Rayaz Ahmed India	12	286 1.0×	122 0.6×	104 0.6×	110 0.7×	105 1.6×	55	459
Woo‐Sung Min South Korea	14	323 1.1×	87 0.5×	104 0.6×	136 0.9×	119 1.9×	34	451

Countries citing papers authored by Ralph Vogler

Since Specialization

Citations

This map shows the geographic impact of Ralph Vogler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Vogler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Vogler more than expected).

Fields of papers citing papers by Ralph Vogler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Vogler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Vogler. The network helps show where Ralph Vogler may publish in the future.

Co-authorship network of co-authors of Ralph Vogler

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Vogler. A scholar is included among the top collaborators of Ralph Vogler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Vogler. Ralph Vogler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Berman, Ellin, et al.. (1997). Long‐term follow‐up of three randomized trials comparing idarubicin and daunorubicin as induction therapies for patients with untreated acute myeloid leukemia. Cancer. 80(S11). 2181–2185. 1 indexed citations

Berman, Ellin, et al.. (1997). Long-term follow-up of three randomized trials comparing idarubicin and daunorubicin as induction therapies for patients with untreated acute myeloid leukemia. Cancer. 80(S11). 2181–2185. 24 indexed citations

Raza, Azra, Harvey D. Preisler, George P. Browman, et al.. (1993). Long Term Outcome of Patients with Acute Myelogenous Leukemia: The Role of Maintenance Therapy, Consolidation Therapy and the Predictive Value of Twoin vitroAssays. Leukemia & lymphoma. 10(1-2). 57–66. 2 indexed citations

Raza, Azra, Harvey D. Preisler, Beatrice C. Lampkin, et al.. (1993). Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemia. American Journal of Hematology. 42(2). 147–157. 13 indexed citations

Goldberg, Jack, Azra Raza, John M. Bennett, et al.. (1993). Mitoxantrone and 5‐azacytidine for refractory/relapsed ANLL or CML in blast crisis: A leukemia intergroup study. American Journal of Hematology. 43(4). 286–290. 19 indexed citations

Raza, Azra, Harvey D. Preisler, Richard A. Larson, et al.. (1993). Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia. American Journal of Hematology. 42(4). 359–366. 11 indexed citations

Raza, Abbas, Judith D. Goldberg, Richard A. Larson, et al.. (1993). CELL-CYCLE CHARACTERISTICS - ALTERABLE DETERMINANTS OF REMISSION DURATION IN A STUDY OF 179 STANDARD RISK NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID-LEUKEMIA. International Journal of Oncology. 2(2). 301–7. 6 indexed citations

Larson, Richard A., Roger Day, N. Azarnia, et al.. (1992). The selective use of AMSA following high‐dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study. British Journal of Haematology. 82(2). 337–346. 13 indexed citations

Raza, Azra, Sefer Gezer, J Anderson, et al.. (1992). Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.. PubMed. 20(10). 1194–200. 22 indexed citations

10.

Larson, Richard A., Azra Raza, George P. Browman, et al.. (1991). The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure. British Journal of Haematology. 79(3). 390–397. 21 indexed citations

11.

Khan, Shakila P., Azra Raza, Maurice Barcos, et al.. (1991). Cell cycle and clinical characteristics of patients with acute myeloid leukemia and myelodysplasia whose biopsies are reactive with anti-factor VIII antibody. Leukemia Research. 15(1). 51–57. 3 indexed citations

12.

Raza, Azra, Harvey D. Preisler, Beatrice C. Lampkin, et al.. (1991). Biological significance of cell cycle kinetics in 128 standard risk newly diagnosed patients with acute myelocytic leukaemia. British Journal of Haematology. 79(1). 33–39. 21 indexed citations

13.

Sato, Hiroshi, Harvey D. Preisler, Roger Day, et al.. (1990). MDR₁ transcript levels as an indication of resistant disease in acute myelogenous leukaemia. British Journal of Haematology. 75(3). 340–345. 157 indexed citations

14.

Preisler, Harvey D., R. L. Priore, N. Azarnia, et al.. (1986). Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements. British Journal of Haematology. 63(4). 625–636. 34 indexed citations

15.

Raza, Azra, Richard A. Larson, George P. Browman, et al.. (1986). Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia. Cancer Chemotherapy and Pharmacology. 18(3). 257–60. 3 indexed citations

16.

Preisler, Harvey D., Azra Raza, N. Azarnia, et al.. (1985). Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: Relationship to response to remission induction therapy. European Journal of Cancer and Clinical Oncology. 21(5). 563–571. 15 indexed citations

17.

Preisler, Harvey D., Joshua Epstein, Azra Raza, et al.. (1984). Inhibition of DNA synthesis by cytosine arabinoside: Relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the disease. European Journal of Cancer and Clinical Oncology. 20(8). 1061–1068. 9 indexed citations

18.

Gessner, Teresa, N. Azarnia, W. Bolanowska, et al.. (1984). Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia. Cancer Chemotherapy and Pharmacology. 12(2). 125–30. 53 indexed citations

19.

Preisler, Harvey D., N. Azarnia, Azra Raza, et al.. (1984). Relationship between the per cent of marrow cells in S phase and the outcome of remission‐induction therapy for acute nonlymphocytic leukaemia. British Journal of Haematology. 56(3). 399–407. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact